87,355 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Acquired by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 87,355 shares of the company's stock, valued at approximately $2,027,000. Raymond James Financial Inc. owned approximately 0.05% of Option Care Health as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in OPCH. Cornerstone Investment Partners LLC raised its position in Option Care Health by 3.6% during the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after purchasing an additional 333 shares during the last quarter. UMB Bank n.a. grew its position in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the last quarter. Assetmark Inc. increased its stake in shares of Option Care Health by 2.0% during the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after buying an additional 487 shares during the period. Pacer Advisors Inc. raised its holdings in shares of Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock valued at $591,000 after acquiring an additional 537 shares in the last quarter. Finally, Sheets Smith Wealth Management lifted its stake in Option Care Health by 2.4% in the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock worth $553,000 after acquiring an additional 550 shares during the period. Institutional investors own 98.05% of the company's stock.

Option Care Health Stock Down 0.2 %

Option Care Health stock traded down $0.07 during mid-day trading on Tuesday, reaching $32.74. The stock had a trading volume of 1,778,385 shares, compared to its average volume of 1,831,081. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a 50-day moving average price of $33.33 and a two-hundred day moving average price of $28.85. The company has a market capitalization of $5.36 billion, a price-to-earnings ratio of 27.51, a PEG ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business's revenue was up 16.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.26 earnings per share. On average, analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have commented on OPCH shares. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reissued a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and lifted their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.